相关实验视频

Updated: Jul 9, 2026

A Three-Dimensional Spheroid Model to Investigate the Tumor-Stromal Interaction in Hepatocellular Carcinoma

A Three-Dimensional Spheroid Model to Investigate the Tumor-Stromal Interaction in Hepatocellular Carcinoma

Published on: September 30, 2021

一个强大的分层集群策略揭示了急性不补偿性肝硬化患者的独特亚组

Sara Palomino-Echeverria¹, Estefania Huergo¹, Asier Ortega-Legarreta¹

¹Unit of Translational Bioinformatics, Navarrabiomed - Fundación Miguel Servet, Pamplona, Spain.

Journal of translational medicine

|June 27, 2024

概括

这项研究介绍了ClustALL,这是一种用于识别复杂疾病患者子组的计算工具. ClustALL成功地分层了缺乏补偿的肝硬化患者,为临床试验设计和疾病管理提供了洞察力.

科学领域:

计算生物学是一种计算生物学.
临床数据科学临床数据科学
生物统计学生物统计学

背景情况:

患者异质性使疾病管理和临床试验设计复杂化.
目前的分类可能忽略了与预后无直接关联的关键异质性因素.
解决复杂的数据挑战对于准确的患者分层至关重要.

研究的目的:

为无监督患者分层开发一个强大的计算管道 (ClustALL).
识别跨种群和算法参数稳定的患者子组.
将ClustALL应用于急性不补偿性肝硬化,并评估其临床效用.

主要方法:

开发了ClustALL,这是一个处理混合类型,缺失和对线临床数据的管道.
用无监督学习来进行患者分层.
基于人口和基于参数的强度的过分层.
在独立的欧洲和拉丁美洲队列中验证的发现.

主要成果:

使用入院数据,ClustALL在急性不补偿性肝硬化中确定了五个强大的分层.
分层包括肝功能标志物,器官功能障碍和导致事件.
一个三集群分层证明了预后价值,通过后续重新评估得到改善.
结果在单独的前性队列中得到验证.

结论:

ClustALL确定了急性不补偿性肝硬化症的三个不同的患者群.
随着时间的推移跟踪这些集群可以为未来的临床试验策略提供信息.
ClustALL是一种新的,强大的方法,用于复杂疾病的患者分层.

关键词:

在ACLF中,ACLF是ACLF.肝硬化是肝硬化的一种疾病.集群集成是指集群集成.复杂的疾病复杂的疾病.患者的异质性患者的异质性分层分层是指分层分层.没有监督的学习学习.

更多相关视频

Isolation of Regenerating Hepatocytes after Partial Hepatectomy in Mice

Isolation of Regenerating Hepatocytes after Partial Hepatectomy in Mice

Published on: December 2, 2022

Identification and Quantification of Deranged Metabolites in Critically Ill Patients Using NMR-Based Metabolomics

Identification and Quantification of Deranged Metabolites in Critically Ill Patients Using NMR-Based Metabolomics

Published on: November 29, 2024

相关概念视频

Cirrhosis I: Introduction

Cirrhosis I: Introduction

Cirrhosis is a chronic, irreversible liver disease characterized by the widespread replacement of healthy liver tissue with fibrotic scar tissue and the formation of regenerative nodules.Etiology of cirrhosisCirrhosis results from sustained liver injury that triggers progressive fibrosis and structural remodeling. The underlying causes are diverse, encompassing common and less frequent clinical conditions. Regardless of the origin, all causes lead to chronic inflammation, hepatocyte loss, and...

Cirrhosis II: Pathophysiology

Cirrhosis II: Pathophysiology

Cirrhosis is a progressive chronic liver injury caused by prolonged inflammation, excessive fibrotic remodeling, and impaired regeneration. Over time, repeated hepatic insults disrupt the liver’s architecture and function, leading to reduced blood flow, impaired bile drainage, and diminished metabolic capacity.Pathophysiology of cirrhosisCirrhosis arises from three main responses to chronic liver damage: inflammation, immune activation, and hepatocyte death. These processes lead to structural...